Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative timeframes for hemodialysis.

R Vanholder1, N Veys, W Van Biesen

  • 1Renal Division, Department of Internal Medicine, University Hospital Ghent, Belgium. raymond.vanholder@rug.ac.be

Artificial Organs
|March 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wars, disasters and kidneys.

Acta clinica Belgica·2014
Same author

What is the difference between prerenal and renal acute kidney injury?

Acta clinica Belgica·2012
Same author

Nephrotoxicity of anticancer drugs--an underestimated problem?

Acta clinica Belgica·2011
Same author

A unifying hypothesis and a single name for a complex globally emerging infection: hantavirus disease.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
Same author

Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: results of the IRIDIEM study.

Kidney & blood pressure research·2010
Same author

Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS).

Acta clinica Belgica·2008
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

Daily or extended hemodialysis sessions show significant clinical improvements, including better blood pressure and metabolic control. These findings suggest potential benefits over traditional alternate-day dialysis schedules, though further research is needed.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • Traditional maintenance hemodialysis uses an alternate-day schedule with 3-5 hour sessions.
  • Alternative hemodialysis schedules, such as daily or extended sessions (≥8 hours), are being explored.

Purpose of the Study:

  • To evaluate the clinical and metabolic impact of modified hemodialysis timeframes.
  • To assess improvements in patient status compared to conventional dialysis.

Main Methods:

  • Implementation of daily and/or prolonged hemodialysis sessions in several dialysis units.
  • Monitoring of clinical parameters and metabolic status of patients.

Main Results:

  • Dramatic improvements observed in clinical and metabolic status.

Related Experiment Videos

  • Beneficial effects on blood pressure, anemia, potassium, and phosphate levels.
  • Reduced need for pharmacologic interventions for these conditions.

    • Conclusions:

    • Alternative hemodialysis timeframes demonstrate significant patient benefits.
    • Further controlled studies are required to compare long-term morbidity and mortality with traditional methods.